Evidence map›Paper›PMID 35301802›Full record

ArticleThoracic cancer2022

Neuroendocrine tumor secondary to pulmonary hypoplasia: A case report.

Takuro Yukawa, Yuta Ishida, Yoshio Naomoto, Yasumasa Monobe, Takuya Fukazawa, Tomoki Yamatsuji

Open access · goldAbstract readCase Reports
In one paragraph

Article in Thoracic cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Takuro YukawaDepartment of General Surgery, Kawasaki Medical School, Okayama, Japan.
Yuta IshidaDepartment of General Surgery, Kawasaki Medical School, Okayama, Japan.
Yoshio NaomotoDepartment of General Surgery, Kawasaki Medical School, Okayama, Japan.
Yasumasa MonobeDepartment of Pathology 1, Kawasaki Medical School, Okayama, Japan.
Takuya FukazawaDepartment of General Surgery, Kawasaki Medical School, Okayama, Japan.ORCID 0000-0003-2890-0599
Tomoki YamatsujiDepartment of General Surgery, Kawasaki Medical School, Okayama, Japan.
Kawasaki Medical School · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary hypoplasia is diagnosed during the perinatal period and is a cause of death in newborns. However, these developmental abnormalities are diagnosed in adulthood in some cases. A 70-year-old male smoker was diagnosed with stage IIIA pulmonary adenocarcinoma in the right upper lobe with right middle lobe hypoplasia. He subsequently underwent right upper and middle lobectomy with lymph node dissection by video-assisted thoracoscopic surgery. In addition to an invasive adenocarcinoma in the right upper lobe, pathological examination of the hypoplastic lobe revealed neuroendocrine hyperplasia, as well as tumorlets and a typical carcinoid. Eight cases of pulmonary neuroendocrine tumors that developed from pulmonary hypoplasia have been reported to date. Interestingly, all but one case occurred in the right middle lobe. Neuroendocrine cell hyperplasia has been reported to develop in hypoplastic lungs postnatally; therefore, we speculated that the lesion was the origin of these neuroendocrine tumors. Moreover, the pathological findings suggested that atelectasis was involved in the pathogenesis of this rare condition. In adults, when lobar hypoplasia is diagnosed, neuroendocrine tumors should be anticipated.

Indexed as

AdenocarcinomaCarcinoid TumorLung NeoplasmsNeuroendocrine TumorsAdultAgedHumansHyperplasiaInfant, NewbornMalecarcinoidneuroendocrine cell hyperplasiapulmonary hypoplasiatumorlet

Identifiers

PMID35301802
PMCPMC9013649
OpenAlexW4220849142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.